Anaplastic Thyroid Carcinoma: Clinical Trials

1 trial for Anaplastic Thyroid Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Not yet recruiting 1

Follow Anaplastic Thyroid Carcinoma: new trials by email Literature Review of Anaplastic Thyroid Carcinoma trials Research Report on Anaplastic Thyroid Carcinoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pulsed Stereotactic Ablative Radiotherapy (PULSAR) With Systematic Therapy for Thyroid Cancer
Dabrafenib, Trametinib, Pembrolizumab - Anaplastic Thyroid Carcinoma, Thyroid Cancer
Phase 2Not yet recruitingWashington University School of Medicine122026-12-312026-10-21

Narrower conditions

Thyroid Carcinoma, Anaplastic (1)  ·  Thyroid Neoplasms (1)

Broader conditions

Carcinoma (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Head and Neck Neoplasms (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Thyroid Diseases (1)

Interventions

DEAE-Dextran (1)  ·  dabrafenib (1)  ·  pembrolizumab (1)  ·  trametinib (1)

Sponsors

Washington University School of Medicine (1)

Countries

United States (1)

Top investigators

Nikhil Rammohan, MD, PhD (1)